Dexcom, Inc. - Glucose Prediction Method Patent Application EP4664486A3
Summary
The European Patent Office has published patent application EP4664486A3 by Dexcom, Inc. for a method of predicting future blood glucose concentrations using individualized linear black box models. The application details a technique involving estimating impulse response functions within a Reproducing Kernel Hilbert Space and applying linear prediction.
What changed
European patent application EP4664486A3, filed by Dexcom, Inc., describes a novel method for predicting future blood glucose concentrations. The method involves creating an individualized linear black box model of glucose-insulin dynamics by estimating impulse response functions within a Reproducing Kernel Hilbert Space (RKHS). This model is then used with a linear predicting technique to forecast future glucose levels.
This publication represents a new patent application and does not impose immediate compliance obligations. However, companies in the health informatics and medical device sectors, particularly those involved in glucose monitoring and diabetes management, should be aware of this technological development. The application is designated for several European states, indicating potential future market relevance.
Source document (simplified)
NONPARAMETRIC GLUCOSE PREDICTORS
Search Report EP4664486A3 Kind: A3 Mar 18, 2026
Applicants
Dexcom, Inc.
Inventors
DEL FAVERO, Simone, FACCHINETTI, Andrea, FACCIOLI, Simone, PILLONETTO, Gianluigi, SPARACINO, Giovanni
Abstract
A method of predicting future blood glucose concentrations of an individual patient includes: identifying an individualized linear black box model of glucose-insulin by estimating a plurality of impulse response functions each accounting for an input-output relation of a plurality of individualized patient data sets, the impulse response functions being functions in a Reproducing Kernel Hilbert Space (RKHS); and applying a linear predicting technique to the selected model using the identified impulse response functions to obtain a predicted blood glucose concentration of the individual patient at a future time.
IPC Classifications
G16H 50/20 20180101AFI20260206BHEP G16H 50/50 20180101ALI20260206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Health Informatics (G16H) publishes new changes.